瑞芬太尼复合丙泊酚麻醉在宫腔镜手术麻醉中的应用分析.docVIP

精品论文 参考文献 瑞芬太尼复合丙泊酚麻醉在宫腔镜手术麻醉中的应用分析 王兰兰 （江苏省中西医结合医院麻醉科 江苏 南京 210028） 【摘要】 目的：对在宫腔镜手术麻醉中应用瑞芬太尼与丙泊酚复合麻醉的临床疗效及安全性进行分析。方法：选取98例我院收治的需要进行宫腔镜手术麻醉的患者，随机分为研究组（49例）与对照组（49例），研究组给予瑞芬太尼复合丙泊酚诱导麻醉，对照组给予芬太尼复合丙泊酚诱导麻醉，对比分析两组患者的喉罩置入情况、拔管时间、术后苏醒时间及不良反应的发生情况。结果： 研究组患者插入喉罩时的体动发生率（14.29%）明显低于对照组（32.65%），差异有统计学意义（Plt;0.05）。研究组患者的拔管时间与术后苏醒时间分别为（5.98plusmn;1.28）min与（5.77plusmn;1.11）min，均小于对照组患者的（11.83plusmn;2.35）min与（8.88plusmn;2.37）min，差异均有统计学意义（Plt;0.05）。研究组患者22.45%的不良反应发生率与对照组的20.41%差异无统计学意义（Plt;0.05）。结论：对宫腔镜手术麻醉患者采用瑞芬太尼复合丙泊酚麻醉，能够明显降低插入喉罩时的体动发生率，缩短拔管时间及术后苏醒时间，具有疗效确切且安全性良好等优点。 【关键词】 瑞芬太尼；丙泊酚；宫腔镜手术 【中图分类号】R614 【文献标识码】A 【文章编号】2095-1752（2015）33-0216-02 【Abstract】Objective To explore the clinical effect and safety of remifentanyl combined with propofol anesthesia for hysteroscopy. Method 98 patients with anesthesia for hysteroscopy were selected, randomly divided into the experimental group and the control group. The experimental group was given remifentanyl combined with propofol anesthesia, and the control group was given fentanyl combined with propofol anesthesia. The insertion of laryngeal mask, awake time and the occurrence of adverse reactions were compared. Results The incidence of physical movement of the experimental group was less than the control group, the difference was statistically significant (Plt;0.05). The extubation time and awake time of the experimental group both were less than the control group, the difference was statistically significant (Plt;0.05). The incidence of adverse reactions of the experimental group and the control group, the difference was no statistically significant (Plt;0.05). Conclusion The remifentanyl combined with propofol anesthesia for hysteroscopy can obviously reduce the total amount of intraoperative propofol, shorten extubation time and awake time and reduce the incidence of physical movement. In addition, it has the advantages of good curative effect and security.